cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.6084/m9.figshare.9209390
title: Soil fungal communities differ between shaded and sun-intensive coffee plantations in El Salvador

description: We collected soil samples from a sun coffee system, shade coffee system, and nearby forest from Izalco, Sonsonate, El Salvador. At each coffee system, we collected soil samples from the surface (upper) and 10 cm below the surface (lower), and from the coffee plant drip line (drip line) and the walkway between two plants (walkway). Forest samples were collected from the soil surface only. We used high-throughput ITS meta-barcode sequencing to characterize soil fungal communities and assigned fungal taxa to functional guilds using FUNGuild. <br>Dataset includes R code for main analyses (coffee_R.R). Main files to bring in for that code are the feature table (ASV x sample matrix) = "table-with-taxonomy2.biom", metadata file = "sample_metadata_coffee_final2.txt", tree file = "tree.nwk". Second R file is for the analyses after funguild categories were assigned (coffee_R_funguild.R). The same files are brought in except the taxonomy file to use is "coffee_taxonomy_funguild.csv" which has the funguild assignments.
DOI: 10.6084/m9.figshare.9209351
title: Moss traits and distribution dataset - Dataset and R script

description: Data and R code to perform an extended version of the RLQ analysis, taking into account space and phylogenetic information, as developed in Pavoine et al., 2011 - Journal of Ecology. Analysis used in Fernández-Martínez et al., Towards a moss sclerophylly continuum: evolutionary history, water chemistry and climate control traits of hygrophytic mosses<br>
DOI: 10.6084/m9.figshare.9208982
title: SIMO MAG Table

description: Description of 45 curated metagenome-assembled genomes (MAGs) binned from assemblies of coastal seawater metagenomes collected from Sapelo Island (GA, USA). Sequence data are available as BioProject PRJNA552566 in NCBI.<br>
DOI: 10.6084/m9.figshare.9208949
title: Sphaeridiotrema_pseudoglobulus_combined_results.xlsx

description: The table includes results of bioinformatic transcriptomic analysis of <i>Sphaeridiotrema pseudoglobulus</i> (Trematoda: Psilostomatidae) life cycle stages. Results of quality of transcripts assembling control, orthogroups reconstruction, reciprocal best BLAST hit searching with <i>Psilotrema simillimum</i> (Trematoda: Psilostomatidae), comparison with public databases (NCBI nr, KEGG and Gene Ontology (GO)) and expression level quantification are shown. Nucleotide and amino acid sequences of assembled transcripts and predicted proteins, respectively, are also included.
DOI: 10.6084/m9.figshare.9208982.v1
title: SIMO MAG Table

description: Description of 45 curated metagenome-assembled genomes (MAGs) binned from assemblies of coastal seawater metagenomes collected from Sapelo Island (GA, USA). Sequence data are available as BioProject PRJNA552566 in NCBI.<br>
DOI: 10.6084/m9.figshare.9208946
title: Psilotrema_simillimum_combined_results.xlsx

description: The table includes results of bioinformatic transcriptomic analysis of <i>Psilotrema simillimum</i> (Trematoda: Psilostomatidae) life cycle stages. Results of quality of transcripts assembling control, orthogroups reconstruction, reciprocal best BLAST hit searching with <i>Sphaeridiotrema pseudoglobulus</i> (Trematoda: Psilostomatidae), comparison with public databases (NCBI nr, KEGG and Gene Ontology (GO)) and expression level quantification are shown. Nucleotide and amino acid sequences of assembled transcripts and predicted proteins, respectively, are also included.
DOI: 10.6084/m9.figshare.9208949.v1
title: Sphaeridiotrema_pseudoglobulus_combined_results.xlsx

description: The table includes results of bioinformatic transcriptomic analysis of <i>Sphaeridiotrema pseudoglobulus</i> (Trematoda: Psilostomatidae) life cycle stages. Results of quality of transcripts assembling control, orthogroups reconstruction, reciprocal best BLAST hit searching with <i>Psilotrema simillimum</i> (Trematoda: Psilostomatidae), comparison with public databases (NCBI nr, KEGG and Gene Ontology (GO)) and expression level quantification are shown. Nucleotide and amino acid sequences of assembled transcripts and predicted proteins, respectively, are also included.
DOI: 10.6084/m9.figshare.9207896
title: Hidden Markov Models for Arsenic related metabolism

description: Hidden Markov Models (HMM) for arsenic related metabolism
DOI: 10.6084/m9.figshare.9208946.v1
title: Psilotrema_simillimum_combined_results.xlsx

description: The table includes results of bioinformatic transcriptomic analysis of <i>Psilotrema simillimum</i> (Trematoda: Psilostomatidae) life cycle stages. Results of quality of transcripts assembling control, orthogroups reconstruction, reciprocal best BLAST hit searching with <i>Sphaeridiotrema pseudoglobulus</i> (Trematoda: Psilostomatidae), comparison with public databases (NCBI nr, KEGG and Gene Ontology (GO)) and expression level quantification are shown. Nucleotide and amino acid sequences of assembled transcripts and predicted proteins, respectively, are also included.
DOI: 10.6084/m9.figshare.9206591
title: ULF Waves near the Plasmapause

description: The code, results from simulations, observations from the CRRES and DMSP satellites used in the paper "ULF Waves Generated near the Plasmapause by the Magnetosphere-Ionosphere Interactions" by A.V. Streltsov and E.V. Mishin, submitted to JGR-Space Physics
DOI: 10.6084/m9.figshare.9207896.v1
title: Hidden Markov Models for Arsenic related metabolism

description: Hidden Markov Models (HMM) for arsenic related metabolism
DOI: 10.6084/m9.figshare.9206591.v1
title: ULF Waves near the Plasmapause

description: The code, results from simulations, observations from the CRRES and DMSP satellites used in the paper "ULF Waves Generated near the Plasmapause by the Magnetosphere-Ionosphere Interactions" by A.V. Streltsov and E.V. Mishin, submitted to JGR-Space Physics
DOI: 10.6084/m9.figshare.9206546
title: Body weight and heart weight raw data

description: body weight and heart weight raw data
DOI: 10.6084/m9.figshare.9206546.v1
title: Untitled Item

description: body weight and heart weight raw data
DOI: 10.6084/m9.figshare.9206384
title: 1_Supplemental material_Endometrial liquid biopsy provides a miRNA roadmap of the secretory phase of the human endometrium.docx

description: Data contain supplemental tables and figures associated to the research work entitled: "Endometrial liquid biopsy (ELB) provides a miRNA roadmap of the secretory phase of the human endometrium". This work aims to establish an endometrial miRNA roadmap based on ELB during the secetory phase of the menstrual cycle in both natural and hormonal replacement therapy (HRT) cycles.<b><br></b><b>From Supplemental tables 1-3 </b>data reflects list of significantly differentially expressed miRNAs in the comparisons performed betweeen the different phases of both natural and HRT cycles.<br><b>Supplemental table 4</b> contains validated miRNA/mRNA interactions of the miRNAs significantly differentially expressed during the receptive phase in both natural and stimulated cycles.<b><br></b><b>Supplemental Table 5 </b>contains a summary of the number of the differentially expressed miRNAs in the comparisons performed throughout the different phases of the menstrual cycle.<br><b>Supplemental figure 1 </b>reflects the validation of potential candidates to identify endometrial receptivity in both natural and HRT cycles<br><b>Supplemental figure 2 </b>consists of a graphic representation oft he existent correlations between the exprssion of the receptivity-linked miRNAs and their predicted ERA target genes in the different phases of the HRT cycles.<br><b>From supplemental figures 3-6</b>, the raw data of the western blots performed in this study are presented
DOI: 10.6084/m9.figshare.9206384.v2
title: 1_Supplemental material_Endometrial liquid biopsy provides a miRNA roadmap of the secretory phase of the human endometrium.docx

description: Data contain supplemental tables and figures associated to the research work entitled: "Endometrial liquid biopsy (ELB) provides a miRNA roadmap of the secretory phase of the human endometrium". This work aims to establish an endometrial miRNA roadmap based on ELB during the secetory phase of the menstrual cycle in both natural and hormonal replacement therapy (HRT) cycles.<b><br></b><b>From Supplemental tables 1-3 </b>data reflects list of significantly differentially expressed miRNAs in the comparisons performed betweeen the different phases of both natural and HRT cycles.<br><b>Supplemental table 4</b> contains validated miRNA/mRNA interactions of the miRNAs significantly differentially expressed during the receptive phase in both natural and stimulated cycles.<b><br></b><b>Supplemental Table 5 </b>contains a summary of the number of the differentially expressed miRNAs in the comparisons performed throughout the different phases of the menstrual cycle.<br><b>Supplemental figure 1 </b>reflects the validation of potential candidates to identify endometrial receptivity in both natural and HRT cycles<br><b>Supplemental figure 2 </b>consists of a graphic representation oft he existent correlations between the exprssion of the receptivity-linked miRNAs and their predicted ERA target genes in the different phases of the HRT cycles.<br><b>From supplemental figures 3-6</b>, the raw data of the western blots performed in this study are presented
DOI: 10.6084/m9.figshare.9206159
title: Supplementary Note 2: Interview protocol for how government mobilize finance for renewable energy deployment

description: <b>Interview protocol for how government mobilize finance for renewable energy deployment</b>
DOI: 10.6084/m9.figshare.9206159.v1
title: Supplementary Note 2: Interview protocol for how government mobilize finance for renewable energy deployment

description: <b>Interview protocol for how government mobilize finance for renewable energy deployment</b>
DOI: 10.6084/m9.figshare.9206153
title: Spanish Lysholm Validation_ArroyoMorales.sav

description: Dataset of a Spanish validation of the Lysholm Questionnaire
DOI: 10.15131/shef.data.9206123
title: Data for Ligand Shell Structure in Lead Sulfide-Oleic Acid Colloidal Quantum Dots Revealed by Small-angle Scattering

description: Underlying data for a paper accepted for publication in The Journal of Physical Chemistry Letters, American Chemical Society, entitled "Ligand Shell Structure in Lead Sulfide-Oleic Acid Colloidal Quantum Dots Revealed by Small-angle Scattering". http://dx.doi.org/10.1021/acs.jpclett.9b01008.
DOI: 10.15131/shef.data.9206123.v1
title: Data for Ligand Shell Structure in Lead Sulfide-Oleic Acid Colloidal Quantum Dots Revealed by Small-angle Scattering

description: Underlying data for a paper accepted for publication in The Journal of Physical Chemistry Letters, American Chemical Society, entitled "Ligand Shell Structure in Lead Sulfide-Oleic Acid Colloidal Quantum Dots Revealed by Small-angle Scattering". http://dx.doi.org/10.1021/acs.jpclett.9b01008.
DOI: 10.6084/m9.figshare.9206087
title: Integration of hexavalent diphtheria, tetanus, acellular pertussis, hepatitis B virus, inactivated poliomyelitis and Haemophilus influenzae type b conjugate vaccine within existing national recommendations following a birth dose of monovalent hepatitis B virus vaccine: results of a systematic review in the Asia Pacific region

description: <b>Introduction</b>: In Asia Pacific, most countries recommend a monovalent hepatitis B virus (HBV) vaccine dose at birth followed by primary vaccination series including three or four doses of combination vaccines against diphtheria, tetanus, and pertussis, with or without <i>Haemophilus influenzae</i> type b (Hib), HBV or poliomyelitis antigens. If hexavalent conjugate vaccines against diphtheria-tetanus-acellular pertussis-HBV-inactivated poliovirus-Hib (DTPa-HBV-IPV/Hib) replace the vaccines included in the primary vaccination series, co-administration of lower-valent vaccines would be avoided but infants would receive ≥4 doses of HBV-containing vaccines before the age of 2 years. <b>Areas covered</b>: We searched for clinical trials conducted in the South-East Asia and Western Pacific Regions (World Health Organization geographic definition), investigating vaccination regimens with &gt;3 doses of HBV-containing vaccines in infants, including a monovalent HBV vaccine birth dose and ≥1 dose of GSK’s hexavalent DTPa-HBV-IPV/Hib vaccine. <b>Expert opinion</b>: The six clinical trials included in this review showed that infants who received the monovalent HBV vaccine at birth and three or four doses of DTPa-HBV-IPV/Hib vaccine achieved protective immunogenic titers with a clinically acceptable safety profile. Our results support the integration of hexavalent DTPa-HBV-IPV/Hib vaccine within existing national recommendations in the Asia Pacific region to reduce the number of injections during infancy.
DOI: 10.6084/m9.figshare.9205931
title: Long-term efficacy and cost-effectiveness of infliximab as first-line treatment in rheumatoid arthritis: systematic review and meta-analysis

description: <b>Introduction</b>: Early biological treatment of rheumatoid arthritis (RA) may reverse the autoimmune response in some patients resulting in favorable long-term outcomes. Although the cost-effectiveness of this strategy has been questioned, biosimilar entries warrant the revision of clinical and pharmaco-economic evidence. <b>Areas covered</b>: We conducted a systematic review of randomized controlled trials (RCTs) published up to 24 May 2018 in Pubmed, EMBASE and Cochrane CENTRAL, comparing infliximab with non-biological therapy in patients with RA naïve to methotrexate. We performed meta-analyses for efficacy outcomes at month 6 and years 1 and 2. Six RCTs were identified, involving 1832 patients. At month 6 ACR70 response and remission, and at year 1 ACR20/ACR70 responses and remission were improved significantly with first-line infliximab versus control. The differences were not significant at year 2. We reviewed cost-utility studies, up to 31 October 2018 in PubMed, Cochrane CENTRAL and the CRD HTA databases. Four studies indicated that first-line use of originator infliximab calculated at 2005–2008 prices was not cost-effective. <b>Expert opinion</b>: We demonstrated the efficacy benefits of first-line infliximab therapy up to 1 year in methotrexate-naïve RA. We highlighted the need for standardized reporting of outcomes and conducting cost-effectiveness analyses of first-line biosimilar therapy in RA.
DOI: 10.6084/m9.figshare.9205931.v1
title: Long-term efficacy and cost-effectiveness of infliximab as first-line treatment in rheumatoid arthritis: systematic review and meta-analysis

description: <b>Introduction</b>: Early biological treatment of rheumatoid arthritis (RA) may reverse the autoimmune response in some patients resulting in favorable long-term outcomes. Although the cost-effectiveness of this strategy has been questioned, biosimilar entries warrant the revision of clinical and pharmaco-economic evidence. <b>Areas covered</b>: We conducted a systematic review of randomized controlled trials (RCTs) published up to 24 May 2018 in Pubmed, EMBASE and Cochrane CENTRAL, comparing infliximab with non-biological therapy in patients with RA naïve to methotrexate. We performed meta-analyses for efficacy outcomes at month 6 and years 1 and 2. Six RCTs were identified, involving 1832 patients. At month 6 ACR70 response and remission, and at year 1 ACR20/ACR70 responses and remission were improved significantly with first-line infliximab versus control. The differences were not significant at year 2. We reviewed cost-utility studies, up to 31 October 2018 in PubMed, Cochrane CENTRAL and the CRD HTA databases. Four studies indicated that first-line use of originator infliximab calculated at 2005–2008 prices was not cost-effective. <b>Expert opinion</b>: We demonstrated the efficacy benefits of first-line infliximab therapy up to 1 year in methotrexate-naïve RA. We highlighted the need for standardized reporting of outcomes and conducting cost-effectiveness analyses of first-line biosimilar therapy in RA.
DOI: 10.6084/m9.figshare.9206087.v1
title: Integration of hexavalent diphtheria, tetanus, acellular pertussis, hepatitis B virus, inactivated poliomyelitis and Haemophilus influenzae type b conjugate vaccine within existing national recommendations following a birth dose of monovalent hepatitis B virus vaccine: results of a systematic review in the Asia Pacific region

description: <b>Introduction</b>: In Asia Pacific, most countries recommend a monovalent hepatitis B virus (HBV) vaccine dose at birth followed by primary vaccination series including three or four doses of combination vaccines against diphtheria, tetanus, and pertussis, with or without <i>Haemophilus influenzae</i> type b (Hib), HBV or poliomyelitis antigens. If hexavalent conjugate vaccines against diphtheria-tetanus-acellular pertussis-HBV-inactivated poliovirus-Hib (DTPa-HBV-IPV/Hib) replace the vaccines included in the primary vaccination series, co-administration of lower-valent vaccines would be avoided but infants would receive ≥4 doses of HBV-containing vaccines before the age of 2 years. <b>Areas covered</b>: We searched for clinical trials conducted in the South-East Asia and Western Pacific Regions (World Health Organization geographic definition), investigating vaccination regimens with &gt;3 doses of HBV-containing vaccines in infants, including a monovalent HBV vaccine birth dose and ≥1 dose of GSK’s hexavalent DTPa-HBV-IPV/Hib vaccine. <b>Expert opinion</b>: The six clinical trials included in this review showed that infants who received the monovalent HBV vaccine at birth and three or four doses of DTPa-HBV-IPV/Hib vaccine achieved protective immunogenic titers with a clinically acceptable safety profile. Our results support the integration of hexavalent DTPa-HBV-IPV/Hib vaccine within existing national recommendations in the Asia Pacific region to reduce the number of injections during infancy.
DOI: 10.6084/m9.figshare.9205793
title: Design Thinking and Agile Software Development in Practice

description: Technology companies are under enormous pressure to remain competitive. In this situation, the time that takes to reach the market for an innovative idea about a product or service is crucial. Large corporations in the IT industry like SAP, Google, IBM, Microsoft, Apple and startups acknowledge that Design Thinking—along with other approaches—is one promising avenue to become more innovative and helps to accelerate the process. This article presents a brief overview of Design Thinking as well as what, in practice, technology companies are actually implementing under the rubric of “Design Thinking” and the challenges reported on a survey conducted among professionals in this field. <br>
DOI: 10.6084/m9.figshare.9205793.v1
title: WorkSpreadsheet.xlsx

description: Survey on DT and SD in the practice.
DOI: 10.6084/m9.figshare.9205793.v2
title: Design Thinking and Agile Software Development in Practice

description: Technology companies are under enormous pressure to become innovative. In this situation, the time that takes to reach the market for an innovative idea about a product or service is crucial. Large corporations in the IT industry like SAP, Google, IBM, Microsoft, Apple and startups acknowledge that Design Thinking—along with other approaches—is one promising avenue to become more innovative and helps to accelerate the process. This article presents a brief overview of Design Thinking as well as what, in practice, technology companies are actually implementing under the rubric of “Design Thinking” and the challenges reported on a survey conducted among professionals in this field.<br>
DOI: 10.6084/m9.figshare.9205793.v4
title: Design Thinking and Agile Software Development in Practice

description: Technology companies are under enormous pressure to remain competitive. In this situation, the time that takes to reach the market for an innovative idea about a product or service is crucial. Large corporations in the IT industry like SAP, Google, IBM, Microsoft, Apple and startups acknowledge that Design Thinking—along with other approaches—is one promising avenue to become more innovative and helps to accelerate the process. This article presents a brief overview of Design Thinking as well as what, in practice, technology companies are actually implementing under the rubric of “Design Thinking” and the challenges reported on a survey conducted among professionals in this field. <br>
DOI: 10.6084/m9.figshare.9205793.v3
title: Design Thinking and Agile Software Development in Practice

description: Technology companies are under enormous pressure to become innovative. In this situation, the time that takes to reach the market for an innovative idea about a product or service is crucial. Large corporations in the IT industry like SAP, Google, IBM, Microsoft, Apple and startups acknowledge that Design Thinking—along with other approaches—is one promising avenue to become more innovative and helps to accelerate the process. This article presents a brief overview of Design Thinking as well as what, in practice, technology companies are actually implementing under the rubric of “Design Thinking” and the challenges reported on a survey conducted among professionals in this field.<br>
DOI: 10.6084/m9.figshare.9205367
title: Raw data of graphene oxide and N-irradiated graphene

description: This folder contains the rawdata of a graphene oxide sample and a graphene sample irradiated by nitrogen.<br>
DOI: 10.6084/m9.figshare.9205295
title: testfile

description: test file for ucsc genome browser.
DOI: 10.6084/m9.figshare.9205367.v1
title: GO_N-Gr_STEM

description: This folder contains the rawdata of a graphene oxide sample and a graphene sample irradiated by nitrogen.<br>
DOI: 10.6084/m9.figshare.9205292
title: Imaging Fluorescence Measurements of Black Plastic Particles Measured With 450 nm Excitation

description: The data contains imaging fluorescence measurements of black plastic particles in the spectral range from 500 nm to 900 nm. The files are stored in the envi-format used typically for hyperspectral data. Therefore there are two files for each measurement: the data (.envi) and the header-file (.envi.hdr). The files can be opened with software like ENVI or the Imanto<i>viewer </i>(https://www.iws.fraunhofer.de/de/geschaeftsfelder/chemische_oberflaechentechnik/prozess_monitoring/produkte/imanto.html). The measurements were made with a lab system developed for imaging fluorescence measurements. For excitation a 2000 mW 450 nm diode laser was used. The samples were also illuminated with a 870 nm LED. For more information please have a look at the reference paper. For each polymer approximately 400 particles were measured. Per measurement around 40 particles were placed on a Si-wafer an scanned with the system and ten measurements were done per polymer. The measured polymers are HDPE, PP, SBR, PA6, PA6 with glassfiber, PA66, PA66 with glass fibre, PA66 with flame retarder, TPU, TPE, TEEE, PPS, PBT and POM. The samples were obtained from a recycling plant and the plastic was grinded cryogenically at the plant.The data was used to train classification models. The objective is to use the method for recycling black plastics.<br><br>
DOI: 10.6084/m9.figshare.9205295.v1
title: testfile

description: test file for ucsc genome browser.